From the publishers of JADPRO

Bone Protection Resource Center

Advertisement

Interview With Paul Sieber, MD: Optimizing Dose and Duration of Therapy With BMAs

Last Updated: Friday, July 17, 2026

Advertisement
Case Studies

Unknown Primary Cancer Presenting as Osteolytic Bone Lesion

Diagnosis and Management of Bone Metastasis in Stage IV Breast Cancer

Dosing and Duration of BMAs in an Older Patient With Prostate Cancer

Take our brief survey to share how your practice manages bone health

Take Survey Now
Fast Facts

Fast Facts #3: Prostate Cancer and Bone Metastases

Advertisement
Quizzes
Test your knowledge on treating bone mets in advanced cancer
Test your knowledge on the use of bone-modifying agents in patients with metastatic lung cancer
Test your knowledge on the use of bone-modifying agents in patients with prostate cancer